273 related articles for article (PubMed ID: 17006765)
1. Pro-angiogenic cytokines and their role in tumor angiogenesis.
Neufeld G; Kessler O
Cancer Metastasis Rev; 2006 Sep; 25(3):373-85. PubMed ID: 17006765
[TBL] [Abstract][Full Text] [Related]
2. [Tumor angiogenesis].
Bikfalvi A
Bull Cancer; 2007; 94(7 Suppl):F193-8. PubMed ID: 17964996
[TBL] [Abstract][Full Text] [Related]
3. Biology of angiogenesis in tumors of the gastrointestinal tract.
Reinmuth N; Parikh AA; Ahmad SA; Liu W; Stoeltzing O; Fan F; Takeda A; Akagi M; Ellis LM
Microsc Res Tech; 2003 Feb; 60(2):199-207. PubMed ID: 12539174
[TBL] [Abstract][Full Text] [Related]
4. Regulators of angiogenesis as targets for anti-angiogenic tumor therapy.
Breier G; Heidenreich R; Gaumann A; Groot M; Licht A; Nicolaus A; Schmitz J; Reichmann E; Plate KH; Vajkoczy P
Ann Hematol; 2002; 81 Suppl 2():S71-2. PubMed ID: 12611084
[No Abstract] [Full Text] [Related]
5. Vascular endothelial growth factor as a survival factor in tumor-associated angiogenesis.
Affara NI; Robertson FM
In Vivo; 2004; 18(5):525-42. PubMed ID: 15523889
[TBL] [Abstract][Full Text] [Related]
6. Targeting angiogenesis with antibodies for the treatment of cancer.
Andreasson P; Carlsson R
IDrugs; 2005 Sep; 8(9):730-3. PubMed ID: 16118694
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor (VEGF) signaling in tumor progression.
Roskoski R
Crit Rev Oncol Hematol; 2007 Jun; 62(3):179-213. PubMed ID: 17324579
[TBL] [Abstract][Full Text] [Related]
8. Tumorangiogenesis: a network of cytokines.
Hotfilder M; Nowak-Göttl U; Wolff JE
Klin Padiatr; 1997; 209(4):265-70. PubMed ID: 9293460
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor receptor 3 is involved in tumor angiogenesis and growth.
Laakkonen P; Waltari M; Holopainen T; Takahashi T; Pytowski B; Steiner P; Hicklin D; Persaud K; Tonra JR; Witte L; Alitalo K
Cancer Res; 2007 Jan; 67(2):593-9. PubMed ID: 17234768
[TBL] [Abstract][Full Text] [Related]
10. Vascular changes in hepatocellular carcinoma.
Yang ZF; Poon RT
Anat Rec (Hoboken); 2008 Jun; 291(6):721-34. PubMed ID: 18484619
[TBL] [Abstract][Full Text] [Related]
11. Angiogenesis in multiple myeloma.
Jakob C; Sterz J; Zavrski I; Heider U; Kleeberg L; Fleissner C; Kaiser M; Sezer O
Eur J Cancer; 2006 Jul; 42(11):1581-90. PubMed ID: 16797965
[TBL] [Abstract][Full Text] [Related]
12. Tumor angiogenesis--a potential target in cancer chemoprevention.
Bhat TA; Singh RP
Food Chem Toxicol; 2008 Apr; 46(4):1334-45. PubMed ID: 17919802
[TBL] [Abstract][Full Text] [Related]
13. [Angiogenesis and metastasis of carcinoma].
Chen L; Shibasaki F
Clin Calcium; 2006 Apr; 16(4):613- 19. PubMed ID: 16582512
[TBL] [Abstract][Full Text] [Related]
14. Role of the microenvironment in tumor growth and in refractoriness/resistance to anti-angiogenic therapies.
Shojaei F; Ferrara N
Drug Resist Updat; 2008 Dec; 11(6):219-30. PubMed ID: 18948057
[TBL] [Abstract][Full Text] [Related]
15. Angioarrestin: a unique angiopoietin-related protein with anti-angiogenic properties.
Dhanabal M; Jeffers M; LaRochelle WJ; Lichenstein HS
Biochem Biophys Res Commun; 2005 Jul; 333(2):308-15. PubMed ID: 15950186
[TBL] [Abstract][Full Text] [Related]
16. Improving delivery of antineoplastic agents with anti-vascular endothelial growth factor therapy.
Yang AD; Bauer TW; Camp ER; Somcio R; Liu W; Fan F; Ellis LM
Cancer; 2005 Apr; 103(8):1561-70. PubMed ID: 15754332
[TBL] [Abstract][Full Text] [Related]
17. Anti-angiogenic therapy against gastrointestinal tract cancers.
Iwasaki J; Nihira S
Jpn J Clin Oncol; 2009 Sep; 39(9):543-51. PubMed ID: 19531544
[TBL] [Abstract][Full Text] [Related]
18. Emerging role of apelin as a therapeutic target in cancer: a patent review.
Rayalam S; Della-Fera MA; Kasser T; Warren W; Baile CA
Recent Pat Anticancer Drug Discov; 2011 Sep; 6(3):367-72. PubMed ID: 21612576
[TBL] [Abstract][Full Text] [Related]
19. Tumor angiogenesis.
Voravud N; Charuruk N
J Med Assoc Thai; 1999 Apr; 82(4):394-404. PubMed ID: 10410503
[TBL] [Abstract][Full Text] [Related]
20. The reduction in pigment epithelium-derived factor is a sign of malignancy in ovarian cancer expressing low-level of vascular endothelial growth factor.
Tsuchiya T; Nakahama K; Asakawa Y; Maemura T; Tanaka M; Takeda S; Morita M; Morita I
Gynecol Endocrinol; 2009 Feb; 25(2):104-9. PubMed ID: 19253105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
